New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

This is the first genome-wide association study of perioperative myocardial infarction, using prospective cohorts of ... with missing genotypes or phenotypic information. In stage II, we tested the ...

A study suggests that those under age 65 may need no restrictions at all, but more data would help clarify the issue.

AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...

For patients with either NSTEMI or STEMI, American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that intravenous unfractionated heparin (UFH) be dosed by weight ...

Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for ...

Scorpion Therapeutics Inc. is selling its lead drug in testing for breast cancer and other advanced solid tumors, to Eli ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...

This research roundup discusses researchers’ new developments in using AI to identify subtypes of Type II Diabetes, gathering ...